Gamma‐glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus

Increased plasma activity of gamma‐glutamyltransferase (GGT) is associated with cardiovascular diseases (CVD) and mortality in the general population. We investigated the association between GGT, CVD and mortality in individuals with diabetes mellitus.

[1]  L. Adams,et al.  Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment , 2011, Nature Reviews Endocrinology.

[2]  Vilmundur Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .

[3]  D. van der A,et al.  External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes , 2010, Diabetologia.

[4]  D. van der A,et al.  Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus , 2010, Diabetologia.

[5]  T. Pischon,et al.  Plasma &ggr;-Glutamyltransferase, Cysteinyl-Glycine, and Oxidized Low-Density Lipoprotein: A Pathway Associated With Myocardial Infarction Risk? , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[6]  D. Grobbee,et al.  Cohort profile: the EPIC-NL study. , 2010, International journal of epidemiology.

[7]  G. Targher.  Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review , 2010, Clinical chemistry and laboratory medicine.

[8]  D. Jacobs,et al.  Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[9]  A. Deshpande,et al.  Epidemiology of Diabetes and Diabetes-Related Complications , 2008, Physical Therapy.

[10]  D. Balzi,et al.  Prognostic value of serum liver enzymes levels in type 2 diabetic patients , 2007, Diabetes/metabolism research and reviews.

[11]  J. Tardif,et al.  Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. , 2007, Journal of the American College of Cardiology.

[12]  D. Jacobs,et al.  Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. , 2006, European heart journal.

[13]  P. Giral,et al.  Letter regarding article by Ruttmann et al, "gamma-Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults". , 2006, Circulation.

[14]  M. Emdin,et al.  Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. , 2005, Circulation.

[15]  H. Concin,et al.  γ-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults , 2005, Circulation.

[16]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[17]  Y. Nikitin,et al.  Gamma-glutamyltransferase and risk of stroke: the eurostroke project (J. Epidemiol Community Health. — 2002. — Feb. — Vol. 56 Suppl 1. —P. 25—29: англ.) , 2002, Neurology Bulletin.

[18]  J. Whitfield.  Gamma Glutamyl Transferase , 2001, Critical reviews in clinical laboratory sciences.

[19]  H. Boeing,et al.  Recruitment Procedures of EPIC-Germany , 1999, Annals of Nutrition and Metabolism.

[20]  S. Ebrahim,et al.  Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. , 1995, American journal of epidemiology.

[21]  H. Boeing,et al.  Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. , 1999, Annals of nutrition & metabolism.